10X GENOMICS INC's ticker is TXG and the CUSIP is 88025U109. A total of 306 filers reported holding 10X GENOMICS INC in Q4 2020. The put-call ratio across all filers is 0.38 and the average weighting 1.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $31,972 | -54.4% | 775,086 | -38.3% | 0.12% | -50.4% |
| Q2 2023 | $70,153 | +19.7% | 1,256,326 | +19.6% | 0.24% | +14.2% |
| Q1 2023 | $58,585 | -98.7% | 1,050,089 | +1675.0% | 0.21% | +1666.7% |
| Q1 2022 | $4,500,000 | -64.7% | 59,159 | -30.9% | 0.01% | -58.6% |
| Q4 2021 | $12,757,000 | +78.0% | 85,642 | +73.9% | 0.03% | +70.6% |
| Q3 2021 | $7,168,000 | -11.5% | 49,239 | +19.1% | 0.02% | -15.0% |
| Q2 2021 | $8,097,000 | -87.6% | 41,348 | -88.6% | 0.02% | -88.0% |
| Q1 2021 | $65,549,000 | -19.9% | 362,146 | -37.4% | 0.17% | -22.7% |
| Q4 2020 | $81,877,000 | +32.2% | 578,226 | +16.4% | 0.22% | +9.1% |
| Q3 2020 | $61,941,000 | +31.3% | 496,805 | -5.9% | 0.20% | +20.0% |
| Q2 2020 | $47,165,000 | -4.1% | 528,103 | -33.1% | 0.16% | -24.3% |
| Q1 2020 | $49,176,000 | -1.4% | 789,091 | +20.7% | 0.22% | +31.3% |
| Q4 2019 | $49,855,000 | +34.9% | 653,835 | -10.8% | 0.17% | +31.7% |
| Q3 2019 | $36,949,000 | – | 733,124 | – | 0.13% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Venrock Management VI, LLC | 962,309 | $188,439,000 | 95.08% |
| Foresite Capital Management II, LLC | 1,753,528 | $343,376,000 | 92.37% |
| Foresite Capital Management I, LLC | 750,000 | $146,865,000 | 88.53% |
| 12 West Capital Management LP | 1,922,000 | $376,366,000 | 15.78% |
| Financial Consulate Inc. | 141,258 | $27,661,000 | 9.97% |
| FINANCIAL CONSULATE, INC | 141,258 | $27,661,000 | 9.97% |
| Meritech Capital Associates V L.L.C. | 1,793,871 | $351,276,000 | 7.51% |
| Andar Capital Management HK Ltd | 51,000 | $9,987,000 | 6.81% |
| JS Capital Management LLC | 540,589 | $105,858,000 | 5.12% |
| Renaissance Capital LLC | 97,281 | $19,050,000 | 3.01% |